In temples and churches, sensory rooms remove barriers for neurodivergent worshipers
That was the case for Lark Losardo's son Percy, who in 2017 began attending Catholic Mass with his family at age 7. Percy, who is autistic, was often overwhelmed by the Brooklyn church's open space, noise and crowds. At first, when he needed to move around or stim (engage in repetitive actions to self-regulate), he'd leave the service with a parent. Eventually, in part because of the barriers to attending as a family, they stopped coming altogether.
Then, in 2020, the Losardos moved to Maplewood, New Jersey. After watching online services at a nearby Catholic parish called St. Joseph's during the pandemic, Lark Losardo learned in 2024 that the parish was opening a sensory room equipped with regulation tools, including a weighted blanket, touch pillow, ear defenders and sound machine. Thanks to that room, today Percy is back in the pews, using the room to regroup whenever needed.
"It speaks volumes,' Lark Losardo told Religion News Service. 'Not everyone needs this space, but just having it there sends a very clear message.'
___
This content is written and produced by Religion News Service and distributed by The Associated Press. RNS and AP partner on some religion news content. RNS is solely responsible for this story.
___
Across the U.S., families like Percy's who once thought worship was off-limits are returning to faith communities thanks to a small but growing number of sensory rooms in religious settings. Located in underutilized classrooms, storage spaces and former nurseries, these rooms vary in size and appearance, but are all designed to offer a calm, predictable environment that can help with nervous system regulation. Disability advocates say the rooms signal that a community prioritizes the needs of neurodivergent and disabled members.
At St. Joseph's, the Rev. Jim Worth said the new sensory room, which opened in December, isa natural extension of the parish's faith values. To him, the room is evidence that inclusion — a principle Worth linked to Catholic social teaching — isn't just given lip service.
'When you put intentionality behind something, it makes a world of difference,' said Worth.
On a 60-degree day in late March, the church, located on a quiet residential street, had a front stoop featuring three signs: one quoting Martin Luther King Jr., another quoting Pope Francis, and a third welcoming anyone in the community to visit the Still Waters Sensory Room.
Named after the biblical Psalm 23 passage — 'he leads me beside still waters' — the sensory room was converted from an unused confessional. It was designed by Together We Bloom, a Maplewood-based nonprofit that helps make events and spaces more accessible. The room's dark indigo walls match the comfortable chair glider and beanbag, each contributing to the soothing atmosphere. The total cost of the room was under $2,000 and was largely paid for by church funds, plus some donations.
'This sensory room has really changed everything for us,' said Pavitra Makam, a St. Joseph's parishioner and mother of two neurodivergent kids. 'Being able to worship together has been the biggest thing for our family.'
Jay Perkins, who has been in the sensory room business since 2009, said it's often parents in need of a safe, supportive space for their kids who are spearheading the movement to build sensory rooms. When his daughter began exhibiting signs of aggression at age 4, places like libraries (too quiet), playgrounds (too loud) and trampoline parks (too crowded) were inaccessible. That applied to his Episcopal church, too.
'There are so few places where special-needs kids with sensory integration disorders can enjoy it,' said Perkins.
The lack of accessible spaces for his family inspired Perkins to begin building the kinds of rooms his daughter would thrive in. In 2018 he officially launched his company, The Sensory Room, which builds high-end, durable sensory rooms from start to finish and trains people on how to use them.
'It's catching on,' said Perkins, whose company built roughly a dozen rooms in 2022 and 80 in 2023. Though The Sensory Room specializes in schools, Perkin's company has also built rooms for a Broadway theater and an airport, and three in evangelical churches. Most of his custom rooms, he told RNS, start in the $20,000 range.
One of those projects was the $35,000 transformation of a storage room into a state-of-the-art sensory room at Encounter Church, an evangelical congregation about 30 minutes from Dallas. Completed in February 2024, the renovation included interactive tactile and texture panels, bubble tubes, mirrors, new carpet, paint and electrical work, and an LED-star ceiling complete with a digital shooting star. According to the Rev. Chris Binion, who co-founded the church with his wife, Tracy, the decision to create the room was prompted by the Holy Spirit.
'I was in a season of prayer and fasting, and I felt like the Lord asked me how to take care of his 'littles,'' Binion told RNS. He felt God was urging him to support kids with 'diverse needs,'including autism. 'We decided through the direction of the Holy Spirit to say yes, and move forward in this kingdom assignment."
It's not just churches that are revamping spaces to focus on sensory integration. Temple Emanu-El, a Reform synagogue in Atlanta, has adapted two of its rooms to help folks process sensory input. A former cry room just off the main sanctuary was altered to become the Shalom Sanctuary, a small space with a large window facing the main worship space equipped with fidget toys, beanbags and headphones.
The synagogue also received a $10,000 grant from the Jewish Federation of Greater Atlanta to improve the accessibility of a classroom. That renovation is almost complete, and the room, which features a wall of sensory engagement toys, flexible furniture and alternative seating (think large rubber balls), will be especially helpful for children who need sensory breaks during religious classes or events such as the annual Purim carnival, according to Rabbi Rachael Klein Miller, associate rabbi at the synagogue.
'Something important in Judaism is the idea that we are all created 'b'tzelem Elohim,' in the image of God,' said Klein Miller. 'And much of that is connected to the golden rule of treating people the way we want to be treated and finding space for everybody in the community.'
According to Rebecca Barlow, a regional disability specialist in The Church of Jesus Christ of Latter-day Saints, adding a sensory room to a house of worship doesn't automatically make it accessible to those with sensory needs. 'It's just one piece of a bigger machine that you're trying to build,' said Barlow, disability specialist for the Desert Ridge Stake in Mesa, Arizona.
The first step to building that machine, Barlow said, is asking disabled individuals and their families what it would take to make church feasible for them. When she first became a disability specialist roughly five years ago, feedback was invaluable. 'The biggest thing was listening. The parents of these children know what they need,' said Barlow, who is the parent of a child with autism.
Based on the families' input, she created a sensory room in her meeting house with new donated items. Knowing it would be used by kids who could become aggressive, she removed hard chairs and chalkboard lips that could pose safety risks. She also filled the room with the usual sensory items, added light-blocking curtains and included a night-light that projected a calming light pattern.
Still, it took more than that to get families back in the door.
"We, as parents of disabled children, often can become jaded, and we lack trust that our children are going to be cared for in a manner appropriate to how special they are,' said Barlow.
To build trust with families, church leaders invited some members of the ward to serve as one-on-one aides for each child with a disability. The aides were trained in the homes of their assigned families and eventually accompanied the kids in the sensory room during church meetings. Barlow also introduced the kids to the sensory room ahead of time via pictures and tours, and ward members, too, received basic training on understanding disabilities and how to use the sensory room.
In the few years since that sensory room opened, the model has gained traction. Barlow says the seven wards in her stake now each have their own disability specialists and sensory rooms, and she routinely takes calls from LDS church members across the country and the globe seeking to set up sensory rooms of their own.
'It feels like we're seeing a cultural shift toward understanding and accepting and integrating people with disabilities,' said Barlow. 'If we want to follow Christ, if we want to emulate him, if we want to be his disciples … they need to be foremost in our mind.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
32 minutes ago
- CBS News
Dr. Mehmet Oz says applications for $50 billion rural hospital fund will go out "in early September"
Washington — Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz said Sunday that applications for a fund for rural hospitals will go out in "early September" in the wake of Medicaid cuts in President Trump's signature piece of legislation passed by Congress last month. "We're putting $50 billion. The president wants this, the Congress wants this," Oz said on "Face the Nation with Margaret Brennan." Mr. Trump signed the so-called "big, beautiful bill" into law last month, which included a number of his second-term priorities from tax cuts to increased spending on border security, defense and energy production. The legislation was paid for in part by significant cuts to health care programs, like Medicaid, which provides government-sponsored health care for low-income and disabled Americans. Among the cuts to Medicaid, the new law will lower provider taxes, which states use to help fund their portion of Medicaid costs. Lawmakers sought to supplement the cuts with a rural hospital stabilization fund after some GOP senators expressed concern over how rural hospitals could be impacted by the Medicaid restrictions, allocating $50 billion for rural hospitals. Oz outlined that rural hospitals will receive applications for the fund in early September. He said the money is designed to help with "workforce development, right-sizing the system and using technology to provide things like telehealth that can change the world." "Imagine if we can change the way we think about the delivery of health and make it more about getting people healthy who can thrive and flourish and be fully present in their own lives and as Americans," Oz said. The new law will also make changes to Medicaid work requirements for some able-bodied adults, along with more frequent eligibility checks. The Congressional Budget Office estimated that the legislation would result in 11.8 million Americans losing health coverage under Medicaid over the next decade. Oz touted the work requirements, saying "every Democratic president and Republican president has said that the foundation of a healthy welfare system, a social system of support, is work." He outlined that the requirements can also be met through community engagement, education and in caretaking roles, and that the administration began pursuing pilot programs when the bill was signed to demonstrate how technology can support the changes. But Brennan noted that according to KFF Health Policy, 92% of adult Medicaid recipients already are working or are caregivers or qualify for other exceptions. Oz said "they're fine." "We want to help connect you to the job market and get you into work," Oz said of people who are considered able-bodied. "The goal of health care insurance is to catalyze action in the right direction, to get you healthier, to give you agency over the future, so you recognize you matter, and you should have a job, therefore, to go out and change the world."
Forbes
an hour ago
- Forbes
UnitedHealth Stock Is Cracking Despite Strong Earnings—Here's What Wall Street Sees
UnitedHealth just reported billions in quarterly profit. Earnings were strong. The company sounded stable. And yet, Wall Street is dumping the stock. Shares are trading near multi-year lows, underperforming peers, and reacting poorly to each quarterly release. The market doesn't move like this for nothing—so what's really going on? Markets often sniff out risks long before they're made official. The headlines are piling up: government investigations, operational failures, and leadership questions, but the price has already started to discount something deeper. Investors are trained to react to numbers. But when structure breaks, the numbers are often the last to go. This isn't about a soft quarter. The model itself is cracking, and the market sees it. The way UnitedHealth generates earnings, the incentives behind its vertical integration, and the regulatory heat all point to fragility that isn't captured in consensus spreadsheets. The market is whispering what many investors don't want to admit: that something is changing here. And once trust fades, the re-rating isn't temporary. It's structural. UnitedHealth Stock: Big, Profitable, Misunderstood UnitedHealth trades with a market value of about $226 billion, against $400 billion in revenue for 2024, with 2025 revenue expected to reach mid‑$445 billion to $448 billion. Size doesn't really equal a safe company; it often hides the fragility beneath. Most investors can't describe how the business works. They see adjusted EPS. They don't question the mechanics. They assume that anything producing this much cash must be built to last. But what looks durable can rot from the inside. The core of UnitedHealth's engine is vertical integration. Optum decides on care, delivers it, and pays itself. One hand washes the other, all under the same roof. It's efficient when unexamined. But regulators are finally paying attention. When the payer, provider, and data all sit in one unit, it becomes harder to separate health outcomes from billing outcomes. Investors often mistake size for insulation. But complexity cuts both ways. When that model starts to wobble, through government probes, whistleblower claims, or unexplained earnings distortions, it doesn't usually collapse overnight. It slowly leaks. This is what we are witnessing. The price action is the tell. This isn't about sentiment anymore. It's about what the market now knows; the market no longer trusts what it thought it understood. You can see it is undone. Slowly at this point. But it's picking up. UnitedHealth Is In The Crosshairs Of The Regulators The Department of Justice now runs both criminal and civil investigations into UnitedHealth's Medicare Advantage billing, officially confirmed on July 24, 2025. Washington is targeting diagnostic coding and risk adjustment practices tied to higher payouts. A process investigators say may have involved pressure, bonuses, and algorithmic recommendations to staff for certain lucrative diagnoses. At the center is Optum, UnitedHealth's massive care delivery and analytics arm, which assigns diagnoses, delivers services, and influences payer reimbursement. That vertical structure underpinned margin expansion until it became a regulatory vulnerability. Congress and CMS are now eyeing those same incentives for bundled services that may prioritize profit over care. And according to multiple reports, lawmakers are drafting reforms to Medicare Advantage to clamp down on what they see as systemic abuse. This is more than a compliance issue. If enforcement leads to fines or limits on Optum's ability to steer claims, UnitedHealth loses both margin and narrative. The company disclosed a potential settlement cost of $1.6 billion tied specifically to these investigations. For investors, this isn't a question of past performance but future structure. If Washington forces a redesign in how payer, provider, and auditor relationships operate within Optum, valuation multiples change. You won't see regulatory risk on a spreadsheet. It's not in the line items. But it's in every fund manager's head. And the market is already pricing that doubt. Earnings Vs. Trust UnitedHealth keeps beating the numbers. But the market's not cheering anymore, and that should make investors stop to think. Second‑quarter 2025 adjusted EPS came in at $4.08, while GAAP net earnings per share were about $3.74, reflecting a 9‑10% spread. This isn't a one-off. The company has leaned on adjustments for several quarters, removing charges from cyberattacks, restructuring, litigation, and 'normalizing' expense items. Each quarter it gets harder to square the adjusted reality with the actual income statement. Investors have tolerated this because the stock used to respond. Now, even beats fall flat. The post-earnings reaction in July was strong, with headline numbers, and yet shares sank over 4%. It's not the earnings they're questioning. It's the whole premise. When the market no longer trusts the adjustment logic, the premium unwinds. At some point, 'adjusted' starts sounding like wishful thinking. That's a dangerous pivot for a stock that trades on perceived consistency. The issue here is credibility. And when credibility gets questioned in a complex, vertically integrated healthcare giant with active DOJ probes and massive opacity in its internal operations, the path forward narrows quickly. UnitedHealth's numbers still impress. But the market is no longer listening to the numbers alone. It's watching what they're trying to cover. Optum: The Black Box That Powered Growth At UnitedHealth For years, Optum was UnitedHealth's crown jewel. It gave the company vertical integration that most healthcare giants could only dream of. Run the insurer. Own the doctor's office. Control the pharmacy benefit manager. Route the claims. Capture every step of the dollar. Investors praised it as genius. Until now. Optum was built for margin expansion. By combining payer and provider, UnitedHealth collapsed the value chain into itself. But that same structure is now drawing fire. Regulators are asking whether a company can truly manage care outcomes and approve and profit from the services being recommended. This questions their entire integration strategy. What used to be pitched as 'scale and efficiency' now looks like opacity. Good luck getting through an Optum report without needing aspirin halfway. It's all intentional. In a market that once rewarded complexity, investors are shifting toward simplicity and transparency. Optum is the opposite. Here's the rub: the more essential Optum is to UnitedHealth's story, the more exposed the company becomes to scrutiny. Break the chain or just shake investor faith in it and the premium vanishes. Optum was once the crown jewel. Now it's the bullseye. The Cyberattack Was A Wake-Up Call At UnitedHealth When Change Healthcare, an Optum subsidiary, was hit by a massive ransomware attack earlier this year, most investors treated it as a one-off disruption. It wasn't. It was a systemic failure that revealed how fragile UnitedHealth's infrastructure had become and how slow its leadership was to respond. The breach paralyzed billing and claims systems for weeks across the U.S. healthcare network. Providers couldn't get paid. Pharmacies stalled. Patients were caught in the middle. For a company that sells itself on reliability and integration, the collapse of a core system fully exposed them to operational risk. But the real damage was reputational. CEO Andrew Witty's delayed response and lack of transparency during the fallout shook investor confidence. For a business model that depends on centralized control, a failure of this scale felt like the opposite of control. The market didn't punish the stock immediately, but the tone shifted. Since the hack, UnitedHealth stock has lagged peers, failed to respond to buybacks, and sold off post-earnings despite beats, indicating trust erosion. In healthcare, operational execution is the product. And the cyberattack told the market what the earnings couldn't: UnitedHealth may be bigger than ever, but its foundation isn't as solid as the numbers suggest. Defensive Stocks Are No Longer Safe Havens Investors once treated UnitedHealth like a bond proxy. It was dependable, defensive, and cash-rich, perfect in a zero-rate world, but the world has moved on. And the assumptions that supported its premium are unraveling with it. But investors have moved on. Higher rates change everything. Safety no longer commands a valuation premium. If anything, it draws sharper scrutiny. Now, capital seeks efficiency and flexibility. It rotates out of perceived stability the moment cracks appear. That's exactly what's happening with UnitedHealth. It's mainly about multiples. Stocks like UnitedHealth were priced on the assumption that growth would stay steady, margins wouldn't come under pressure, and regulators would remain passive. That's no longer the case. Every part of the thesis, from Medicare Advantage economics to Optum's integration, is under review. And the old multiple doesn't hold under new conditions. At 9 to 10 times forward earnings, UnitedHealth stock is still priced for control. But what happens if growth slows, scrutiny increases, and earnings quality erodes? That multiple doesn't hold when earnings wobble and faith erodes. And that's what we're starting to see. The idea that defensive means safe no longer applies. In a world where capital costs more and scrutiny cuts deeper, structural risk matters more than past predictability. And UnitedHealth is showing investors what happens when they confuse size for safety. Market Behavior Is Telling The market is speaking louder than the press release. UnitedHealth's earnings keep beating expectations, yet the stock keeps bleeding. After the Q2 2025 print, shares opened higher and then reversed, again indicating doubt from the market. Buybacks, once the reliable support mechanism, are falling flat. As of the April 2025 10‑Q, the board authorized repurchasing 27 million shares, not a dollar amount. Share count & price suggest a rough upper bound of ~$13 billion (assuming ~$500/share), but no official dollar figure exists. The tape hasn't cared. Investors aren't paying for stability anymore. They're questioning the model, and the price is reflecting it. This keeps happening. Strong numbers, weak tape. That's no coincidence. The market is reacting to what those earnings might not be showing. When price action diverges consistently from headline strength, something underneath is shifting. You don't need management to confirm what the price already knows. Scenarios Investors Must Weigh Every investor in UnitedHealth needs to face a simple question: what exactly is being priced in? The stock is still valued like nothing structurally will change. That's the best-case scenario: a regulatory slap on the wrist, no breakup, and margins protected. But cracks like these don't usually stop there. The base case is more uncomfortable. It assumes the DOJ and CMS probes gain traction, triggering forced disclosures, tighter reporting standards, and some form of operational reform. That alone could compress margins across Optum, weaken pricing power, and delay capital returns. It would also likely lower the multiple as the market stops assuming permanence in a business model that's now up for review. The worst case? A permanent re-rating. If the government cracks down on how care is authorized and reimbursed, if whistleblower cases uncover deeper abuses, or if investors lose trust in Optum's structure entirely, then UnitedHealth becomes less of a cash machine and more of a litigation risk. That would mean sustained outflows, ESG scrutiny, and index pressure. Right now, the stock trades like the best-case scenario is a given. That's a mistake. Risk is what you don't see coming, and the market has a habit of mispricing structural changes until they happen. UnitedHealth Stock Is Breaking For A Reason UnitedHealth has long benefited from scale, opacity, and the assumption that healthcare complexity equals safety. That illusion is fading. The stock is breaking not because of a single quarter or a bad headline, but because the structure that powered its dominance is now under the microscope. When investors start asking the right questions, eventually price always does. That's what's happening here. The DOJ, CMS, and media aren't just circling; they're probing a business model that was built on internal leverage and integration. When that's challenged, the numbers don't matter as much as the narrative. And UnitedHealth is losing control of its narrative. This isn't a bad value call. It's something deeper—the kind of unraveling that rewrites the whole thesis. Markets don't punish giants like this without reason. When scrutiny hits complexity, it always takes time, but it always resets expectations. UnitedHealth isn't priced for scrutiny. And when the foundation cracks, the market doesn't wait for permission to react; it already has.
Yahoo
an hour ago
- Yahoo
Products with opioid-like effects sold at gas stations may be banned as illicit substances
The Food and Drug Administration (FDA) is recommending banning a compound found in unregulated tablets, gummies and drink mixes sold online and at gas stations and convenience stores, the Trump administration announced this week. The substance, known as 7-OH, will be scheduled as an illicit drug if the Drug Enforcement Administration − a branch of the US Justice Department responsible for classifying drugs as controlled substances − approves the sanction after a review. "Dark innovations in chemistry have exacerbated the addiction crisis in this country," US Department of Health and Human Services Deputy Secretary Jim O'Neil told reporters during a Tuesday, July 29, press conference in Washington DC. "Synthetic opioids like carfentanill and the substance we're here to take action on today: 7-Hydroxymitragynine." O'Neil said 7-hydroxymitragynine, 7-OH, is deliberately addictive and a powerful opioid agonist many times more potent than morphine. Calling it "a recipe for public health disaster," O'Neill, said 7-OH products are often sold without warnings or controls. "We've seen a disturbing rise in reports of overdoses, poisonings and emergency room visits linked to products containing 7-OH,' O'Neil said. "These substances are often sold online or in convenience stores with no quality control, no dosage control and no warnings." 'They've killed thousands and thousands' During the press conference, FDA commissioner Martin Makary spoke alongside US Health and Human Services Secretary Robert F. Kennedy, Jr., as they announced they planned to send warning letters to companies for illegally marketing products containing 7-OH in an effort to combat the country's opioid addiction problem. 'We have a history in public health of being asleep at the wheel,' Makary said. 'Public health is supposed to prevent disasters, not just clean them up after they've killed thousands and thousands of people.' Which states felt tsunami waves? See list of where it hit after Russia earthquake What is 7-OH? The compound 7-OH is a naturally occurring substance in the kratom plant (Mitragyna speciosa), according to the FDA, but only a minor component comprising less than 2% of the alkaloid content in natural kratom leaves. "However, 7-OH demonstrates substantially greater mu-opioid receptor potency than kratom's primary alkaloid constituent mitragynine, as well as other classical opioids such as morphine," the FDA wrote in its findings. Mu-opioid receptors, found in the brain and spinal cord, are primarily responsible for pain relief and other opioid effects like euphoria and respiratory depression, according to research published on the National Institutes of Health's National Library of Medicine. Contributing: Adrianna Rodriguez Natalie Neysa Alund is a senior reporter for USA TODAY. Reach her at nalund@ and follow her on X @nataliealund. (This story was updated to include video.) This article originally appeared on USA TODAY: What is 7-OH? Opioid-like product may get banned by FDA Solve the daily Crossword
